2003
Physician Knowledge of the Diagnosis and Management of Rocky Mountain Spotted Fever
O'REILLY M, PADDOCK C, ELCHOS B, GODDARD J, CHILDS J, CURRIE M. Physician Knowledge of the Diagnosis and Management of Rocky Mountain Spotted Fever. Annals Of The New York Academy Of Sciences 2003, 990: 295-301. PMID: 12860642, DOI: 10.1111/j.1749-6632.2003.tb07379.x.Peer-Reviewed Original ResearchConceptsHealth districtHigh case fatality rateRocky Mountain Spotted FeverDifferent health districtsInitiation of therapyOnset of rashDevelopment of rashOnset of symptomsPrimary care physiciansAntibiotic of choiceCase fatality ratePublic health districtsAppropriate treatment strategyFamily practice physiciansPercent of physiciansTick-borne illnessAgent of choiceEmergency medicine physiciansChildren 8 yearsNonspecific symptomsAntibiotic therapyAppropriate patientsPediatric patientsCare physiciansMedian time
2001
Analysis of Risk Factors for Fatal Rocky Mountain Spotted Fever: Evidence for Superiority of Tetracyclines for Therapy
Holman R, Paddock C, Curns A, Krebs J, McQuiston J, Childs J. Analysis of Risk Factors for Fatal Rocky Mountain Spotted Fever: Evidence for Superiority of Tetracyclines for Therapy. The Journal Of Infectious Diseases 2001, 184: 1437-1444. PMID: 11709786, DOI: 10.1086/324372.Peer-Reviewed Original ResearchConceptsRisk factorsFatal Rocky Mountain Spotted FeverRocky Mountain Spotted FeverOnset of symptomsCase fatality rateTetracycline-class antibioticsPrimary therapyClinical characteristicsOlder patientsAppropriate therapyRMSF casesNonfatal casesNational surveillanceHigh riskSpotted FeverPatientsEffective antibioticsTherapyDeathFeverAntibioticsTreatmentSymptomsFactorsDisease